Search

The increasing sophistication of cancer treatments threatens to outpace the ability of health care providers to enroll patients in clinical trials to test those therapies.

Investigators report an innovative strategy for treating advanced kidney cancer.

Antiviral drugs for hepatitis C reduce liver-related deaths by nearly 50 percent in patients with a history of liver cancer.

A team led by UT Southwestern researchers has identified how SARS-CoV-2, the virus that causes COVID-19, builds a structure called the RNA cap that’s critical for successful viral replication.

The hormone LEAP2, which naturally blocks the “hunger” hormone ghrelin, is elevated in people with obesity, especially after eating – raising hopes for a treatment that could one day more effectively reduce appetite and, hence, obesity.

Dr. Joseph Takahashi, noted for discovering the first gene controlling biological clocks in mammals, addressed the topic at the Society for Neuroscience annual meeting where he was awarded the Gruber Neuroscience Prize for his pioneering work in circadian rhythms.

Starting this fall, the biggest public high schools in Texas are required to report all sports concussions to a central database as part of one of the nation’s largest statewide endeavors to track brain injuries in youth athletics.

UT Southwestern researchers find that humans and mice with pancreatitis are deficient in a stress hormone called FGF21.

When seeking quick pain relief, people should not overuse acetaminophen as a cure-all.

Stories published in 2024 about UT Southwestern Medical Center.